1
David P Kanios, Joseph A Gentile, Juan A Mantelle, Steven Sablotsky: Compositions and methods for topical administration of pharmaceutically active agents. Noven Pharmaceuticals, Foley & Lardner, February 17, 1998: US05719197 (221 worldwide citation)

Compositions for topical application comprising a therapeutically effective amount of a pharmaceutical agent(s), a pharmaceutically acceptable bioadhesive carrier, a solvent for the pharmaceutical agent(s) in the carrier and a clay, and methods of administering the pharmaceutical agents to a mammal ...


2
David P Kanios, Juan A Mantelle, Paul Johnson, Chensheng Li: Packaging system for transdermal drug delivery systems. Noven Pharmaceuticals, Jay G Kolman, June 14, 2005: US06905016 (17 worldwide citation)

A device and method for stabilizing a drug, particularly a chiral drug or the active enantiomer(s) thereof, in a carrier composition of a transdermal delivery system prior to the systems use by providing a product packaging system to prevent or control degradation reactions that can result from cert ...


3
David P Kanios, Rod Hartwig, Juan A Mantelle, David W Houze: Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems. Noven Pharmaceuticals, Foley & Lardner, April 22, 2014: US08703175 (6 worldwide citation)

A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or rel ...


4
David P Kanios, Juan A Mantelle: Compositions and methods for delivery of amino-functional drugs. Noven Pharmaceuticals, Foley & Lardner, May 6, 2014: US08715723 (3 worldwide citation)

Described are flexible, finite systems for the transdermal administration of scopolamine, comprising: (a) a polymer matrix comprising a polymer blend comprising (i) a non-functional acrylic-based polymer constituting at least about 60% by weight of the dry weight of the polymer matrix, and (ii) an a ...


5
Chana Wilson Evans, Robert O Huber, David P Kanios, Gary Lee Loubert, Tiffany Anne Menjoulet, Timothy Paul Mitchell, Linda Sue Nartker, Xavier Jean Paul Thomas: Single phase silicone acrylate formulation. Dow Corning Corporation, Dow Corning France SAS, Howard & Howard Attorneys PLLC, October 29, 2013: US08569416

This invention provides a single phase silicone acrylate formulation that resists phase separation and includes (A) at least one of a silicone, an acrylate, and combinations thereof. The single phase silicone acrylate formulation also includes (B) a silicone acrylate hybrid compatibilizing agent inc ...


6
David P Kanios, Juan A Mantelle, Paul Johnson, Chensheng Li: Packaging system for transdermal drug delivery systems. Noven Pharmaceuticals, Foley & Lardner, May 29, 2012: US08186506

A device and method for stabilizing a drug, particularly a chiral drug or the active enantiomer(s) thereof, in a carrier composition of a transdermal delivery system prior to the systems use by providing a product packaging system to prevent or control degradation reactions that can result from cert ...


7
David P Kanios, Juan A Mantelle: Compositions and methods for delivery of amino-functional drugs. Noven Pharmaceuticals, Foley And Lardner, September 13, 2007: US20070212410-A1

Described are flexible, finite systems for the transdermal administration of scopolamine, comprising: (a) a polymer matrix comprising a polymer blend comprising (i) a non-functional acrylic-based polymer constituting at least about 60% by weight of the dry weight of the polymer matrix, and (ii) an a ...


8
David P Kanios, Juan A Mantelle, Paul Johnson, Chensheng Li: Packaging system for transdermal drug delivery systems. Noven Pharmaceuticals, Noven Pharmaceuticals, Jay G Kolman Esq, November 14, 2002: US20020168401-A1

A device and method for stabilizing a drug, particularly a chiral drug or the active enantiomer(s) thereof, in a carrier composition of a transdermal delivery system prior to the systems use by providing a product packaging system to prevent or control degradation reactions that can result from cert ...


9
David P Kanios, Rod Hartwig, Juan A Mantelle, David W Houze: Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems. Noven Pharmaceuticals, Foley And Lardner, August 4, 2005: US20050169977-A1

A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric and/or adhesive coating that is applied to either the transdermal system's backing or rel ...


10
David P Kanios, Juan A Mantelle, Paul Johnson, Chensheng Li: Packaging system for transdermal drug delivery systems. Noven Pharmaceuticals, Noven Pharmaceuticals, Jay G Kolman Esq, September 29, 2005: US20050214354-A1

A device and method for stabilizing a drug, particularly a chiral drug or the active enantiomer(s) thereof, in a carrier composition of a transdermal delivery system prior to the systems use by providing a product packaging system to prevent or control degradation reactions that can result from cert ...